Skip to main content
European Commission logo

Cancer

Add to pdf basket
©mi_viri #455657879 | source: stock.adobe.com
Identifying telltale markers for personalised lung cancer treatment
T cell therapies are specifically tuned to a patient’s individual tumour, but choosing the right marker is key. A new method for identifying neoantigens in non-small cell lung cancer opens the door to improved treatments. The EU-funded CANVAS project set up a joint pilot study to further the work.
Add to pdf basket
© Bamphen #1410063991 | source: stock.adobe.com
The Serbian lab using scorpion venom to fight cancer
The EU-funded NANOFACTS project helped transform Serbia’s BioSense Institute (BIOS) from a leader in agricultural sensing to a powerhouse for innovative cancer diagnostics and therapies. This project is part of the EU Mission on Cancer, which seeks to improve the lives of over 3 million people by 2030 through prevention, treatment and support for cancer patients and their families, enabling them to live longer and healthier lives.
Add to pdf basket
©piotrurakau #289911916 | source: stock.adobe.com
A new device can sift blood to find cancer – or recruit immune cells for personalised therapy
Metastasis is responsible for over 90 % of cancer-related deaths. Yet little focus has been placed on the elusive cells responsible for spreading the disease, which circulate through the bloodstream, making identification and analysis challenging. The EU-funded SCALPEL project set out to save lives by developing a microchip device to detect and sort metastatic cells from blood samples.
Add to pdf basket
©Moopingz #894718772 | source: stock.adobe.com
Drawing a direct line between cellular acidic resistance and cancer treatment
Cancer is one of the leading causes of death in the EU. Researchers in the EU-funded Survive project examined how cells adapt to acidic conditions – a trait that can allow tumours to grow. Their findings highlight new ways to identify aggressive cancers, and point to potential new treatments to regulate acid resistance.
Add to pdf basket
©scio21 | source: AdobeStock #389912886
New technique to probe tissue flexibility offers improved diagnosis and treatment
Liver disease kills over 130 000 people in Europe every year, driven by obesity, hepatitis and alcohol consumption. The EU-funded FORCE project developed a cutting-edge diagnostic tool to aid early detection of liver disease. The technique, which quantifies the elasticity of soft tissue, can also be used to monitor tumours, improving outcomes for patients undergoing cancer treatment.
Add to pdf basket
©Konstantin Yuganov #482327502 source: stock.adobe.com 2023
Cross-border skills exchange helps children in Lithuania get the cancer treatment they deserve
Paediatric oncology researchers in Lithuania often lack opportunities for international research and training. The EU-funded TREL project helped place 32 specialists from Lithuania in Europe’s leading medical institutions. The programme is already having an impact on the treatment of paediatric cancers in Lithuania, and accelerating scientific excellence in this research area.
Add to pdf basket
©elena #464433613 source: stock.adobe.com 2023
New tools for early detection of ovarian cancer will save lives
Ovarian cancer is often diagnosed too late for treatments to work. The EU-funded EARLYDETECT project developed innovative screening tools capable of detecting the disease early. This will help patients receive the therapies they need sooner, before the disease spreads, saving the lives of citizens in the EU and beyond.
Add to pdf basket
©TuMeggy #426500140 source: stock.adobe.com 2023
Nanotech oxygen to help phototherapy fight tumours
The effectiveness of photodynamic therapy is limited by the lack of oxygen in solid cancers. Now, EU-funded researchers have developed drug delivery nano-carriers to bring oxygen to the tumour site. This strategy could improve the effectiveness of this photodynamic therapy and help to save the lives of citizens affected by cancer.
Add to pdf basket
©Kiattisak #559791231 source: stock.adobe.com 2023
Smart new compounds target both tumours and tropical diseases
Cancer and neglected tropical diseases impact millions of people every year. By identifying compounds that specifically target affected cells, EU-funded researchers have opened the door to potential new treatments. These medicines could save lives and benefit citizens both in Europe and around the world.
Add to pdf basket
© STABVIDA, 2022
Flexible research leads to pocket PCR test for COVID-19
While researchers were busy developing a handheld device to rapidly detect biomarkers to guide the therapy in lung cancer, the pandemic struck. Realising their device could be adapted to test for coronavirus, researchers refocused their work. The result is the market’s smallest portable PCR device.

PDF Basket

No article selected
Convert to PDF Empty basket

Filter stories